Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Casulo C, Larson MC, Lunde JJ, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Mun Y, Masaquel A, Wu M, Wei MC, Shewade A, Li J, Cerhan J, Flowers CR, Link BK, Maurer MJ. Casulo C, et al. Among authors: masaquel a. Lancet Haematol. 2022 Apr;9(4):e289-e300. doi: 10.1016/S2352-3026(22)00033-3. Lancet Haematol. 2022. PMID: 35358443 Free PMC article.
Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US.
Guzauskas GF, Masaquel A, Reyes C, Bernaards C, Krivasi T, Veenstra DL. Guzauskas GF, et al. Among authors: masaquel a. J Med Econ. 2018 Oct;21(10):960-967. doi: 10.1080/13696998.2018.1489254. Epub 2018 Jul 6. J Med Econ. 2018. PMID: 29898619 Free article. Clinical Trial.
Maintenance rituximab in Veterans with follicular lymphoma.
Halwani AS, Rasmussen KM, Patil V, Morreall D, Li C, Yong C, Burningham Z, Dawson K, Masaquel A, Henderson K, DeLong-Sieg E, Sauer BC. Halwani AS, et al. Among authors: masaquel a. Cancer Med. 2020 Oct;9(20):7537-7547. doi: 10.1002/cam4.3420. Epub 2020 Aug 28. Cancer Med. 2020. PMID: 32860335 Free PMC article.
Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine.
Danilov AV, Yimer HA, Boxer MA, Burke JM, Babu S, Li J, Mun Y, Trask PC, Masaquel AS, Sharman JP. Danilov AV, et al. Among authors: masaquel as. Clin Lymphoma Myeloma Leuk. 2022 Feb;22(2):121-128. doi: 10.1016/j.clml.2021.09.008. Epub 2021 Sep 11. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34674981 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36164051
Patients' priorities in selecting chronic lymphocytic leukemia treatments.
Mansfield C, Masaquel A, Sutphin J, Weiss E, Gutierrez M, Wilson J, Boeri M, Li J, Reyes C. Mansfield C, et al. Among authors: masaquel a. Blood Adv. 2017 Oct 31;1(24):2176-2185. doi: 10.1182/bloodadvances.2017007294. eCollection 2017 Nov 14. Blood Adv. 2017. PMID: 29296865 Free PMC article.
46 results